Neeraj Sharma

Array ( [id] => 6252509 [patent_doc_number] => 20100028446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'TRANSPORT OF DRUGS VIA THE BLOOD-BRAIN BARRIER BY MEANS OF APOLIPOPROTEINS' [patent_app_type] => utility [patent_app_number] => 12/449408 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2989 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028446.pdf [firstpage_image] =>[orig_patent_app_number] => 12449408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574972 [patent_doc_number] => 20090142333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Activin-actriia antagonists and uses for promoting bone growth in cancer patients' [patent_app_type] => utility [patent_app_number] => 12/012525 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23092 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142333.pdf [firstpage_image] =>[orig_patent_app_number] => 12012525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866825 [patent_doc_number] => 20080145884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'SFRP AND PEPTIDE MOTIFS THAT INTERACT WITH SFRP AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/019567 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22446 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145884.pdf [firstpage_image] =>[orig_patent_app_number] => 12019567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420357 [patent_doc_number] => 20100150930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'MAGE-11 AS A MARKER FOR ENDOMETRIAL RECEPTIVITY TO EMBRYO TRANSPLANTATION AND A MARKER AND THERAPEUTIC TARGET IN CASTRATION-RECURRENT PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/524388 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16362 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150930.pdf [firstpage_image] =>[orig_patent_app_number] => 12524388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887549 [patent_doc_number] => 20080261881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Use of human chorionic gonadotropin (HCG) orally or for injection for the treatment of mood disorders and alcoholism' [patent_app_type] => utility [patent_app_number] => 12/007596 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1362 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261881.pdf [firstpage_image] =>[orig_patent_app_number] => 12007596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6317141 [patent_doc_number] => 20100112605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Biomarker for the Medicine and the Biology of the Reproduction' [patent_app_type] => utility [patent_app_number] => 12/521793 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12310 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112605.pdf [firstpage_image] =>[orig_patent_app_number] => 12521793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676164 [patent_doc_number] => 20080213794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'SCREENING FOR GESTATIONAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/971598 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17292 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213794.pdf [firstpage_image] =>[orig_patent_app_number] => 11971598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12790 [patent_doc_number] => 07807178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Muteins of placental growth factor type I, preparation method and application thereof' [patent_app_type] => utility [patent_app_number] => 11/967469 [patent_app_country] => US [patent_app_date] => 2007-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 12462 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807178.pdf [firstpage_image] =>[orig_patent_app_number] => 11967469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6252094 [patent_doc_number] => 20100028361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'BRAIN-DERIVED GONADOTROPINS AND COGNITION' [patent_app_type] => utility [patent_app_number] => 12/520320 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12821 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028361.pdf [firstpage_image] =>[orig_patent_app_number] => 12520320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558227 [patent_doc_number] => 20090269804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Methods for refolding proteins containing free cysteine residues' [patent_app_type] => utility [patent_app_number] => 12/001639 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45069 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269804.pdf [firstpage_image] =>[orig_patent_app_number] => 12001639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6419601 [patent_doc_number] => 20100150862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METHODS OF MODULATING MATERNAL-FETAL TOLERANCE' [patent_app_type] => utility [patent_app_number] => 12/516458 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18859 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150862.pdf [firstpage_image] =>[orig_patent_app_number] => 12516458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718620 [patent_doc_number] => 20080241142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Neuropilin/VEGF-C/VEGFR-3 Materials and Methods' [patent_app_type] => utility [patent_app_number] => 11/947622 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22391 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241142.pdf [firstpage_image] =>[orig_patent_app_number] => 11947622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765832 [patent_doc_number] => 20080177044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Novel saitohin gene and uses of same' [patent_app_type] => utility [patent_app_number] => 11/985584 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15022 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177044.pdf [firstpage_image] =>[orig_patent_app_number] => 11985584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340097 [patent_doc_number] => 20100247552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'PAK MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/514288 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 57441 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247552.pdf [firstpage_image] =>[orig_patent_app_number] => 12514288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630908 [patent_doc_number] => 20100035275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM' [patent_app_type] => utility [patent_app_number] => 12/514194 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2334 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035275.pdf [firstpage_image] =>[orig_patent_app_number] => 12514194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764683 [patent_doc_number] => 20080175894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPEITIC GROWTH FACTORS' [patent_app_type] => utility [patent_app_number] => 11/932383 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 56565 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11932383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428171 [patent_doc_number] => 20090087481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS' [patent_app_type] => utility [patent_app_number] => 11/931295 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 56565 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087481.pdf [firstpage_image] =>[orig_patent_app_number] => 11931295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807502 [patent_doc_number] => 20080171080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS' [patent_app_type] => utility [patent_app_number] => 11/931326 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 56561 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171080.pdf [firstpage_image] =>[orig_patent_app_number] => 11931326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845457 [patent_doc_number] => 20080181865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS' [patent_app_type] => utility [patent_app_number] => 11/931618 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 56592 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181865.pdf [firstpage_image] =>[orig_patent_app_number] => 11931618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314715 [patent_doc_number] => 20100112038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS' [patent_app_type] => utility [patent_app_number] => 11/931128 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 56576 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11931128 [rel_patent_id] =>[rel_patent_doc_number] =>)